Life Cancer Center
Combination of CRS and HIPEC offers Effective Treatment and Higher Chance of Survival for patients with Peritoneal Metastases
“Metastatic cancer” is an illness that no one would wish to experience, nor would they want their loved ones to go through it. Patients may feel hopeless and assume there is no cure for the disease. However, a treatment option is available in the form of an advanced technology known as HIPEC, combined with CRS. This treatment method has shown to effectively treat peritoneal metastases, or cancer that has spread to the abdominal cavity, and improve the chances of survival.